Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Monoclonal Antibody Therapy After Allogeneic Stem Cell Transplantation in Treating Patients With Persistent or Progressive Cancer
This study has been suspended.
Study NCT00060372 Information provided by National Cancer Institute (NCI)
First Received: May 6, 2003 Last Updated: May 12, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Leukemia
Lymphoma
Myelodysplastic Syndromes
Neuroblastoma
Ovarian Cancer
Testicular Germ Cell Tumor
Additional conditions recognized in this trial
Breast Neoplasms
Multiple Myeloma
Neoplasms
Neoplasms, Germ Cell and Embryonal
Neoplasms, Plasma Cell
Ovarian Neoplasms
Preleukemia
Syndrome
More general conditions related to this trial
Adnexal Diseases
Blood Protein Disorders
Bone Marrow Diseases
Breast Diseases
Cardiovascular Diseases
Disease
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive, Peripheral
Ovarian Diseases
Paraproteinemias
Pathologic Processes
Precancerous Conditions
Skin Diseases
Urogenital Neoplasms
Vascular Diseases
Interventions listed in this trial
ipilimumab
therapeutic allogeneic lymphocytes
adjuvant therapy
Sponsors listed in this trial
University of California, San Diego
National Cancer Institute (NCI)
Back to top of Main Content
